Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes.-MedSci.cn

Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes.

Meador, CB; Digumarthy, S; Yeap, BY; Farago, AF; Heist, RS; Marcoux, JP; Rangachari, D; Barbie, DA; Piotrowska, Z

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务